Effect of Full Length Parathyroid Hormone, PTH(1-84) or Strontium Ranelate on Bone Markers in Postmenopausal Women With Primary Osteoporosis (FP-006-IM)
PHASE4
The primary objective of this trial is to show that PTH(1-84) is superior t...
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
PHASE4
The aim of this study is to directly compare the bone forming effects of 20...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.